Tag Archives: s. 101

Top Ten List of Patent News Stories in 2018

Although this list will reach most the readers of Patents4Life after 2019 begins, 2018 deserves some attention even if it has the feel of “those we lost in 2018” lists. Although most of my colleague-commentators have published their lists by … Continue reading

Posted in 2018 Patent News, Section 101 | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Legal Wiggle Room in the Joint AIPLA-IPO Proposal on Patentability?

I recently took another look at the Joint AIPLA-IPO Proposal on Patent Eligibility that was prompted by the scheduling of a discussion meeting by the Minnesota Intellectual Property Law Association. I confess that I did not participate in either the … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Life Science Patenting to Iancu – “We need help too!”

In his remarks presented at the recent 10th Annual Patent Law & Policy Conference at Georgetown University Law School, USPTO Director Andrei Iancu outlined the analytical framework for the new, eagerly awaited, PTO Guidance on patent eligible subject matter. Although … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , | Leave a comment

Director Iancu’s IPO Address and Judge Rich

Although Director Iancu’s address primarily aims at the difficulty of determining when a claim is directed to an abstract idea, his precursor guiding light is clearly the late Judge Giles Rich. Notably, Iancu quotes from Judge Rich. These quotes are … Continue reading

Posted in Section 101 | Tagged , , , , , , , , | Leave a comment